Pieris Pharmaceuticals is a biotechnology company specializing in the development of novel protein therapeutics to treat a range of diseases. Founded in 2001, Pieris is dedicated to leveraging its Anticalin technology platform to create innovative treatments for cancer, respiratory diseases, and other serious medical conditions. The company's cutting-edge approach to drug development has positioned it as a leader in the biopharmaceutical industry, with a strong pipeline of potential therapies that aim to address unmet medical needs and improve patient outcomes.

Refer new talent to Pieris Pharmaceuticals